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Abstract 
(9-Methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-11-yl)hydrazine (1) 
was used as a precursor for preparation of some novel 1-(9-methyl-5,6-
dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-11-yl)-1H-pyrazoles  2–7, -1H-
isoindole-1,3(2H)-dione  8, and -pyridazin-3(2H)-one  9. Moreover, the acyclic 
C-nucleosides  10 and 11 were prepared by treating compound 1 with 
D-glucose. The in vitro antimicrobial activity of the tested compounds was 
evaluated by measuring the zone diameters and some of the prepared products 
showed potent antimicrobial activity in compared with those of well known drugs 
(standard). In general, the non-acetylated sugar hydrazone derivative 10 
showed the highest antibacterial and antifungal potency among the tested 
compounds and standard with IZ = 22, 21 and 22 mm and MIC = 62.5 and 
31.25 μg/ml, respectively. 
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Introduction 
Pyrimidine and fused heterocyclic pyrimidine derivatives have attracted a great deal of 
interest in particular 4-hydrazinopyrimidine derivatives, which were tested for their 
medicinal, bactericidal and fungicidal activity [1–4]. Pyrimidine and heterocyclic annulated 
pyrimidine derivatives attracted great interest due to the wide variety of interesting 
biological activities observed for these compounds, such as anticancer [4], antiviral [5], 
Anti-HIV-1 Activity [6], anti-inflammatory [7] and antimicrobial activities [8]. In addition, 
several substituted dihydronaphthothienopyrimidine derivatives  showed antimicrobial 
activities against Bacillus subtilis, Escherichia coli, Aspergillus niger and Candida albicans 
[9], and their ester-containing derivatives demonstrated more antimicrobial activities than 
the corresponding cyano-containing analogs. In view of the above and in continuation of 
our research program concerned with structural modification of certain biologically active 
heterocyclic nuclei with the purpose of enhancing their biological activity [10–16], we 
aimed to incorporate a fused pyrimidine moiety with other heterocyclic ring system to 
obtain new functions in an attempt to improve the antimicrobial profile of compounds 
containing the dihydronaphthothienopyrimidine ring system. 
Results and Discussion 
From the view of biological activity, polycondensed fused heteroaromatic systems are 
often of much greater interest than the constituent monocyclic compounds. The 
appearance of qualitatively new properties of an annelated molecule, enlargement of the 
possibility of varying pharmacophore groups in different positions of the molecule and the 
ability of the latter to interact with various receptors adopting several conformations are 
apparently of crucial importance [17]. In this investigation, compound 1 [18] was dissolved 
in ethanol and refluxed with (ethoxymethylene)malononitrile, tetracyanoethylene, 
[bis(methylthio)methylene]malononitrile, ethyl (ethoxymethylene)cyanoacetate or methyl 
[bis(methylthio)methylene]cyanoacetate to afford the corresponding substituted pyrazole 
derivatives  2–6, respectively (Sch. 1). The structures of the latter compounds were 
confirmed on the basis of their elemental analysis and spectral data (cf. Exp.). The IR 
spectra of compounds 2–4 showed absorption bands characteristic for NH2 and C≡N 
groups, while those of compounds 5 and 6 revealed absorption bands characteristic for 
NH2 and C=O. Also, the 
1H NMR spectra showed signals at δ = 7.10, 6.55, 6.60, 6.81 and 
7.00 ppm due to NH2 (exchangeable with D2O) for compounds 2–6, respectively. The MS 
gave the molecular ion peaks at m/z (%) = 358 (100), 383 (89), 404 (100), 405 (100), and 
437 (100) for compounds 2–6, respectively. Similarly, when compound 1 was refluxed with 
acetyl acetone the pyrazole derivative 7 was obtained (Sch. 1). The 
1H NMR and 
13C NMR 
spectra of the latter compound showed signals at δ = 2.05, 2.19 ppm and 11.97, 13.29 
ppm for (2CH3), while its IR spectrum revealed the absence of NH, NH2 groups. The MS, 
gave the molecular ion peak at m/z (%) = 346 (78). 
On the other hand, compound 1 was refluxed with tetrachlorophthalic anhydride in glacial 
acetic acid to afford N-imido derivative 8 (Sch. 2). The presence of NH and two C=O 
groups in the IR spectra and the NH-proton (D2O exchangeable) in the 
1H-NMR spectrum 
confirmed its structure. Also, the MS of compound 8 gave fragments showing the isotopic 
pattern due to the presence of chlorine atoms (cf. Exp.).    Studies on the Reactivity of a Tetracyclic Hydrazine Towards Some Reagents for Biological Evaluation  3 
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2-(9-Methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-11-yl)-6-phenyl-
4,5-dihydropyridazin-3(2H)-one  (9) was prepared by heating the hydrazine derivative 1 
with  β-benzoylpropionic acid. Inspection of the IR spectrum of product 9 showed the 
presence of the C=O group and its 
1H NMR spectrum revealed signals at δ 2.43, 3.61 ppm 
for 2CH2 of pyridazine ring. In addition, the 
13C NMR spectrum showed signal at δ 173.80 
accountable for the C=O group (cf. Exp.). 
The hydrazone derivative 10 was prepared by reacting compound 1 with D-glucose in the 
presence of a catalytic amount of glacial acetic acid. The product 10 revealed absorption 
bands for OH and NH groups in IR spectra and its 
1H NMR spectrum showed the 
presence of the sugar protons, NH, and azo-methine (CH=N) (cf. Exp.).  
Acetylation of the hydrazone derivative 10  with acetic anhydride/pyridine at room 
temperature gave unexpected O-acetylated cyclic C-nucleosides 11 (Sch. 2). The absence 
of NH as well as the azo-methine (CH=N) in 
1H NMR spectra confirmed its structure (cf. 
Exp.). Also, the 
13C NMR spectrum showed signals accountable for the acetylated sugar 
residue (cf. Exp.). 
The formation of compound 11 might have taken place via oxidative cyclization of the 
O-acetylated sugar. In general, the Dimroth type rearrangement of S-triazolopyrimidines 
was intensively discussed and verified with X-ray diffraction by Rashad et al [16]. So, the 
triazolo[1,5-c]pyrimidine derivative 11 was obtained directly via  Dimroth type 
rearrangement of its triazolo[4,3-c]pyrimidine derivative. 
Antimicrobial activity  
Tab. 1.   The inhibition zones diameter (IZ) in mm.  
Compound No.  Escherichia 
coli  
Bacillus 
subtilis  
Candida 
albicans 
2  16 16  11 
3  16.5 16  12 
4  16 18  16 
5  12 11  11 
6  11 10  10 
7  11 12  10 
8  12 12  10 
9  20 20  15 
10  22 21  22 
11  12 11  22 
Chloramphenicol 24  24  – 
fluconazole –  –  26 
Highly active (inhibition zone > 20 mm); Moderately active 
(inhibition zone16–19 mm); Slightly active (inhibition zone 11–15 
mm); (–) no inhibition zone 
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The in vitro antimicrobial activity of the tested compounds was evaluated by measuring the 
zone diameters and the results were compared with those of well known drugs (standard). 
Among the tested compounds, for gram-positive and gram-negative bacteria, it was 
noticed that ß-enaminonitriles of pyrazole ring system 2–4 (IZ = 16–18 mm and MIC = 65 
μg/ml) demonstrated inhibitory activities more than β-enaminoesters 5 and 6 (IZ = 10–12 
mm and MIC = 125 μg/ml). However, the pyridazine derivative 9 and non-acetylated sugar 
10 revealed the most significant antibacterial activities (IZ = 20-22 mm and MIC = 62.5 
μg/ml). On the other hand, the non-acetylated sugar 10 and the acetylated cyclic 
C-nucleoside  11  revealed more effective antifungal activity than the other tested 
compounds showing IZ = 22 mm and MIC = 31.25 μg/ml. However, replacement of the 
hydroxyl moiety in 10 by acetyl group in 11 led to decrease the antibacterial potency of 10 
showing IZ = 11, 12 mm, MIC = 62.5 μg/ml and the antifungal activity was not affected. In 
general, the non-acetylated sugar hydrazone derivative 10 showed the highest 
antibacterial and antifungal potency among the tested compounds and standard with IZ = 
22, 21 and 22 mm and MIC = 62.5 and 31.25 μg/ml, respectively. 
Tab. 2. MIC in μg/ml of the most active compounds. 
Compound No.  Escherichia 
coli  
Candida 
albicans 
Bacillus 
subtilis  
4 65  31.25  65 
5 125  31.25  125 
9 62.5  15  62.5 
10 62.5  31.25  62.5 
11 12  31.25  11 
Chloramphenicol 10  –  10 
Fluconazole –  0.5  – 
 
Experimental 
All melting points were uncorrected and measured using an Electro-thermal IA 9100 
apparatus (Shimadzu, Japan). Microanalytical data were performed by Vario El-Mentar 
apparatus (Shimadzu, Japan), National Research Centre, Cairo, Egypt. The IR spectra 
(KBr) were recorded on a Perkin-Elmer 1650 spectrophotometer, National Research 
Centre, Cairo, Egypt. 
1H NMR and 
13C NMR spectra were determined on a Varian Mercury 
(300 MHz) spectrometer (Varian, UK) and the chemical shifts were expressed in ppm 
relative to TMS as internal reference, Faculty of science, Cairo University, Egypt. Mass 
spectra were recorded on 70 eV EI Ms-QP 1000 EX (Shimadzu, Japan), National 
Research Centre, Cairo, Egypt.  
Compound 1 was prepared according to a reported method [18]. 
Preparation of compounds 2–6.  
General procedure 
To a solution of compound 1  (2.82g, 1mmol) in (20 ml) dry ethanol, 
(ethoxymethylene)malononitrile, tetracyanoethylene, [bis(methylthio)methylene]malono-
nitrile, ethyl (ethoxymethylene)cyanoacetate or methyl [bis(methylthio)methylene]cyano-  Studies on the Reactivity of a Tetracyclic Hydrazine Towards Some Reagents for Biological Evaluation  7 
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acetate (1 mmol) was added and the reaction mixtures were refluxed for 2, 5, 4, 3 and 4 h, 
respectively. The products, which separated on cooling, were collected by filtration and 
recrystallized from ethanol to give compounds 2–6.  
5-Amino-1-(9-methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-11-yl)-1H-
pyrazole-4-carbonitrile (2)  
Yield (95%), M.p. 260–262°C; IR (KBr) ν = 3407, 3200 (NH2), 2209 (CN) cm
–1; 
1H NMR 
(DMSO-d6) δ = 2.77 (s, 3H, CH3), 2.95–3.00 (m, 4H, 2CH2), 6.34 (d, J = 8 Hz, 1H, Ar-H), 
6.91–7.31 (m, 5H, 3Ar-H and NH2, D2O exchangeable), 7.55 (s, 1H, C3-H); 
13C NMR 
(DMSO-d6) δ = 25.32 (CH3), 25.67 (C-5'), 29.62 (C-6'), 115.29 (C-4), 118.72 (CN), 125.21, 
126.83, 127.29, 128.12 , 128.47 (Ar-C), 131.89 (C-3), 135.48 (C-6a'), 141.92 (C-11c'), 
143.35 (C-11b'), 150.45 (C-7a'), 153.64 (C-5), 162.16 (C-9'), 172.10 (C-11'); MS, m/z (%): 
358 (M
+, 100). Anal. calcd for C19H14N6S: C, 63.67; H, 3.94; N, 23.45; S, 8.95. Found: C, 
63.62; H, 4.00; N, 23.39; S, 9.01. 
5-Amino-1-(9-methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-11-yl)-1H-
pyrazole-3,4-dicarbonitrile (3) 
Yield (65%), M.p. 166–168 °C; IR (KBr) ν = 3407, 3200 (NH2), 2219 (CN) cm
–1; 
1H NMR 
(DMSO-d6) δ = 2.80 (s, 3H, CH3), 3.00-3.15 (m, 4H, 2CH2), 6.25 (d, J = 8 Hz, 1H, Ar-H), 
6.55 (s, 2H, NH2, D2O exchangeable), 7.00-7.26 (m, 3H, Ar-H); 
13C NMR (DMSO-d6) δ = 
25.14 (CH3), 25.23 (C-5'), 29.18 (C-6'), 110.68 (CN), 116.69 (CN), 124.34, 125.90, 127.25, 
128.05 (Ar-C), 131.05 (C-3), 134.59 (C-6a'), 142.71 (C-11c'), 148.35 (C-11b'), 150.40 (C-
7a'), 152.69 (C-5), 162.16 (C-9'), 173.10 (C-11'); MS, m/z (%): 383 (M
+, 89). Anal. calcd for 
C20H13N7S: C, 62.65; H, 3.42; N, 25.57; S, 8.36. Found: C, 62.60; H, 3.48; N, 25.54; S, 
8.40. 
5-Amino-1-(9-methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-11-yl)-3-
(methylsulfanyl)-1H-pyrazole-4-carbonitrile (4) 
Yield (90%), M.p. 124–126 °C; IR (KBr) ν = 3460, 3346 (NH2), 2215 (CN) cm
–1; 
1H NMR 
(DMSO-d6) δ = 1.58 (s, 3H, SCH3), 2.80 (s, 3H, CH3), 2.90-3.05 (m, 4H, 2CH2), 6.50 (d, J 
= 8 Hz, 1H, Ar-H), 6.60 (s, 2H, NH2, D2O exchangeable), 7.00-7.25 (m, 3H, Ar-H); 
13C 
NMR (DMSO-d6) δ = 11.64 (CH3), 25.15 (CH3), 25.34 (C-5'), 29.32 (C-6'), 113.04 (C-4), 
115.59 (CN), 126.03, 126.16, 126.47, 127.13, 128.51 (Ar-C), 132.50 (C-3), 133.82 (C-6a'), 
140.67 (C-11c'), 150.75 (C-11b'), 151.25 (C-7a'), 153.83 (C-5), 160.17 (C-9'), 172.31 (C-
11'); MS, m/z (%): 404 (M
+, 100). Anal. calcd for C20H16N6S2: C, 59.38; H, 3.99; N, 20.78; 
S, 15.85. Found: C, 59.29; H, 4.05; N, 20.71; S, 15.92. 
Methyl 5-amino-1-(9-methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-11-yl)-1H-
pyrazole-4-carboxylate (5) 
Yield (90%), M.p. 139–141 °C; IR (KBr) ν = 3464, 3354 (NH2), 1685 (C=O) cm
–1; 
1H NMR 
(DMSO-d6) δ = 1.34 (t, J = 6.9 Hz, 3H, CH3), 2.81 (s, 3H, CH3), 2.96–3.07 (m, 4H, 2CH2), 
4.28 (q, J  = 7.5 Hz, 2H, CH2), 6.43 (d, J = 8 Hz, 1H, Ar-H), 6.81 (s, 2H, NH2, D2O 
exchangeable), 6.90-7.35 (m, 4H, 3Ar-H and C3-H); 
13C NMR (DMSO-d6) δ 14.45 (CH3), 
25.17 (CH3), 25.29 (C-5'), 29.32 (C-6'), 59.82 (OCH2), 96.49 (C-4), 125.65, 126.03, 
126.25, 127.33, 128.30 (Ar-C), 131.85 (C-3), 134.14 (C-6a'), 140.77 (C-11c'), 141.41 (C-
11b'), 151.35 (C-7a'), 151.83 (C-5), 160.39 (C-9'), 164.31 (C-11'), 172.29 (C=O); MS, m/z 8  A. E. Rashad et al.:  
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(%): 405 (M
+, 100). Anal. calcd for C21H19N5O2S: C, 62.20; H, 4.72; N, 17.27; S, 7.91. 
Found: C, 62.30; H, 4.65; N, 17.33; S, 7.81. 
Ethyl 5-amino-1-(9-methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-11-yl)-3-
(methylsulfanyl)-1H-pyrazole-4-carboxylate (6) 
Yield (90%), M.p. 250–252 °C; IR (KBr) ν = 3460, 3346 (NH2), 1685 (C=O) cm
–1; 
1H NMR 
(DMSO-d6) δ = 1.45 (s, 3H, SCH3), 2.77 (s, 3H, CH3), 2.97–3.10 (m, 4H, 2CH2), 3.83 (s, 
3H, OCH3), 6.51 (d, J = 8 Hz, 1H, Ar-H), 6.97–7.23 (m, 5H, 3Ar-H and NH2, D2O 
exchangeable); 
13C NMR (DMSO-d6) δ = 11.16 (SCH3), 25.12 (CH3), 25.34 (C-5'), 29.37 
(C-6'), 51.03 (OCH3), 93.95 (C-4), 125.92, 126.27, 126.53, 126.85, 128.78 (Ar-C), 132.76 
(C-3), 133.59 (C-6a'), 139.92 (C-11c'), 150.86 (C-11b'), 151.46 (C-7a'), 153.56 (C-5), 
160.06 (C-9'), 164.52 (C-11'), 172.04 (C=O); MS, m/z (%): 437 (M
+, 100). Anal. calcd for 
C21H19N5O2S2: C, 57.65; H, 4.38; N, 16.01; S, 14.66. Found: C, 57.71; H, 4.33; N, 16.09; 
S, 14.60. 
11-(3,5-Dimethyl-1H-pyrazol-1-yl)-9-methyl-5,6-dihydronaphtho[1',2':4,5]-
thieno[2,3-d]pyrimidine (7) 
To a solution of compound 1 (2.82 g, 1 mmol) in ethanol (20 ml), acetyl acetone (1 mmol) 
was added and the reaction mixture was refluxed for 10 h. The solvent was then removed 
under reduced pressure and the residue was recrystallized from ethanol to give compound 
7. Yield (70%), M.p. 129–131 °C; 
1H NMR (DMSO-d6) δ = 2.05 (s, 3H, CH3), 2.19 (s, 3H, 
CH3), 2.86 (s, 3H, CH3), 2.95–3.03 (m, 4H, 2CH2), 5.91 (s, 1H, C4'-H), 6.10 (d, J = 8 Hz, 
1H, Ar-H), 6.79-7.19 (m, 3H, Ar-H); 
13C NMR (DMSO-d6) δ = 11.97 (CH3), 13.29 (CH3), 
25.04 (CH3), 25.36 (C-5), 29.41 (C-6), 108.56 (C-4'), 119.21, 124.89, 126.19, 126.33, 
127.15, 127.82 (Ar-C), 131.06 (C-3'), 134.49 (C-6a), 140.49 (C-11c), 141.58 (C-11b), 
151.03 (C-7a), 161.85 (C-9), 172.04 (C-11); MS, m/z (%): 346 (M
+, 78). Anal. calcd for 
C20H18N4S: C, 69.34; H, 5.24; N, 16.17; S, 9.26. Found: C, 69.30; H, 5.29; N, 16.09; S, 
9.33. 
4,5,6,7-Tetrachloro-2-[(9-methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-
11-yl)amino]-1H-isoindole-1,3(2H)-dione (8) 
A mixture of compound 1 (2.82 g, 1 mmol) and tetrachlorophthalic anhydride (2.85 g, 1 
mmol) in glacial acetic acid (50 ml) was refluxed for 2 h. The formed precipitate was 
filtered on hot, dried and recrystallized from dioxane to give compound 8. Yield (73%), 
M.p. 285–287 °C; IR (KBr) ν = 3326 (NH) and 1791, 1724 (anhydride CO) cm
–1; 
1H NMR 
(DMSO-d6) δ = 2.35 (s, 3H, CH3), 2.83-3.28 (m, 4H, 2CH2), 7.08-7.35 (m, 2H, Ar-H), 7.85 
(d,  J = 7.2 Hz, 1H, Ar-H), 8.37 (d, J = 7.6 Hz, 1H, Ar-H), 9.60 (s, 1H, NH, D2O 
exchangeable); 
13C NMR (DMSO-d6) δ = 25.10 (CH3), 26.02 (C-5'), 30.13 (C-6'), 98.95 (C-
2a), 125.90, 126.27, 126.71, 126.85, 128.78 (Ar-C), 132.35 (C-3), 134.82 (C-6a'), 139.92 
(C-11c'), 150.68 (C-11b'), 154.46 (C-7a'), 155.50 (C-6a), 160.06 (C-9'), 162.52 (C-11'), 
164.10 (C=O), 168.50 (C=O); MS, m/z (%): 552 (M
+, Cl
37, 11.32), 550 (M
+, Cl
35, 4.72). 
Anal. calcd for C23H12Cl4N4O2S: C, 50.20; H, 2.20; Cl, 25.77; N, 5.82; S, 5.83. Found: C, 
50.31; H, 2.12; Cl, 25.81; N, 5.78; S, 5.90. 
2-(9-Methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-11-yl)-6-phenyl-
4,5-dihydropyridazin-3(2H)-one (9) 
A mixture of compound 1 (2.82 g, 1 mmol) and β-benzoylpropionic acid (1.78 g, 1 mmol) in   Studies on the Reactivity of a Tetracyclic Hydrazine Towards Some Reagents for Biological Evaluation  9 
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ethanol (50 ml) was refluxed for 4 h. The formed precipitate was filtered off hot, dried and 
recrystallized from dioxane to give compound 9. Yield (97%), M.p. 154–156 °C; IR (KBr) ν 
= 1691 (C=O) cm
–1;
 1H NMR (DMSO-d6) δ = 2.43 (m, 5H, CH2 and CH3), 2.81–2.95 (m, 
4H, 2CH2), 3.61 (t, J = 7.5 Hz, 2H, CH2), 7.10–7.45 (m, 9H, Ar-H); 
13C NMR (DMSO-d6) δ 
= 17.74 (CH3), 23.87 (C-5'), 29.35 (C-6'), 39.92 (C-5), 56.64 (C-4), 125.30, 125.85, 126.53, 
127.62, 128.45 (Ar-C), 131.24 (C-3), 134.66 (C-6a'), 139.58 (C-11c'), 150.21 (C-11b'), 
154.40 (C-7a'), 160.25 (C-9'), 162.51 (C-11'), 173.80 (C=O); MS, m/z (%): 424 (M
+, 100). 
Anal. calcd for C25H20N4OS: C, 70.73; H, 4.75; N, 13.20; S, 7.55. Found: C, 70.66; H, 4.81; 
N, 13.12; S, 7.62. 
D-Glucose (9-methyl-5,6-dihydronaphtho[1',2':4,5]thieno[2,3-d]pyrimidin-
11-yl)hydrazone (10) 
A mixture of compound 1 (2.82 g, 1 mmol), D-glucose (1.80 g, 1 mmol), ethanol (30 ml), 
and a catalytic amount of glacial acetic acid (3 drops) was heated at 80 °C for 2 h. The 
formed precipitate was filtered off, dried and recrystallized from ethanol to give compound 
10. Yield (60%), M.p. 142–144 °C; IR (KBr) ν = 3353–3220 (broad, OH+NH) cm
–1; 
1H NMR 
(DMSO-d6) δ = 2.40 (m, 3H, CH3), 2.80–3.02 (m, 4H, 2CH2), 3.20–3.60 (protons of the 
alditol congregated with the solvent absorption) [14], 3.70–3.80 (m, 2H, CH2OH), 4.40-5.11 
(m, 5H, 5OH, D2O exchangeable), 7.05–7.42 (m, 5H, Ar-H and NH, D2O exchangeable), 
8.30 (s, 1H, N=CH); 
13C-NMR (DMSO-d6)  δ = 18.82 (CH3), 25.60 (C-5), 29.63 (C-6), 
61.26, 70.71, 72.78, 77.12, 92.65 (C-alditol), 125.91, 126.20, 126.75, 126.80, 128.74 (Ar-
C), 134.62 (C-6a'), 139.91 (C-11c'), 150.52 (C-11b'), 153.42 (C-7a'), 160.06 (C-9'), 162.51 
(C-11'), 162.90 (N=CH). Anal. calcd for C21H24N4O5S: C, 56.74; H, 5.44; N, 12.60; S, 7.21. 
Found: C, 56.84; H, 5.39; N, 12.69; S, 7.11. 
(1S)-1,2,3,4,5-Penta-O-acetyl-1-C-(5-methyl-8,9-dihydronaphtho[1',2':4,5]-
thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-2-yl)-D-arabinitol (11)  
A solution of compounds 10  (1 mmol) in a mixture of acetic anhydride (10 mL) and 
anhydrous pyridine (10 ml) was stirred at room temperature for 24 h. The reaction mixture 
was poured into ice-water with stirring and the solids that precipitated were collected by 
filtration, washed with water, dried and recrystallized from ethanol to give compounds 11. 
Yield (70%), M.p. 109–111 °C; IR (KBr) ν = 1748 (OAc), 1602 (C=N); 
1H NMR (DMSO-d6) 
δ = 1.80–2.10 (m, 15H, 5OAc), 2.40 (m, 3H, CH3), 2.80–3.10 (m, 6H, 3CH2), 4.20–5.50 (m, 
4H, 4CHOAc), 7.10–7.40 (m, 4H, Ar-H); 
13C-NMR (DMSO-d6) δ = 20.50, 20.62, 20.66, 
20.74, 20.88 (5CH3), 22.70 (C-5'), 29.86 (C-6'), 61.41, 65.90, 67.08, 67.52, 70.52, 73.99 
(C-alditol), 109.91 (C-4), 126.81, 127.24, 127.38, 127.53 (Ar-C), 135.13 (C-3), 136.62 (C-
6a'), 142.12 (C-11c'), 149.52 (C-11b'), 153.40 (C-7a'), 160.10 (C-9'), 162.51 (C-11'), 
169.56, 170.18, 170.59, 170.62, 170.83 (5CO). Anal. calcd for C32H34N4O10S: C, 57.65; H, 
5.14; N, 8.40; S, 4.81. Found: C, 57.55; H, 5.20; N, 8.45; S, 4.80. 
Antimicrobial activity  
In vitro antimicrobial screening  
The newly synthesized compounds were screened for their antibacterial activity against 
one gram positive bacteria, Bacillus subtilis NRRL B-543 and one gram negative bacteria, 
Escherichia coli NRRL B-210 and yeast Candida albicans NRRL Y-477.  These 
microorganisms were obtained from Northern Utilisation Research and Development 
Division, U.S. Departement of Agricultural Peoria, Illinois, USA. Chloramphenicol and 10  A. E. Rashad et al.:  
Sci Pharm. 2010; 78; 1–12. 
Fluconazole were purchased (pure form) from Egyptian market and used in a 
concentration of 2 mg/ml as references for antibacterial and antifungal activities. These 
compounds were assayed by the agar diffusion method [19]. The assay medium flasks 
containing 50 ml of nutrient agar medium for bacteria and Czapek’s-Dox agar media for 
yeast. The holes each of 9 mm diameter were made by scooping out medium with a 
sterilized cork borer in a petri dish which was seeded with the organisms. The solutions of 
each test compound (0.10 ml) were added separately in the holes and Petri dishes were 
subsequently incubated. The incubation was carried out at 30°C for 24h. Simultaneously, 
controls were maintained by employing 0.10 ml of dimethylsulfoxide (DMSO) which did not 
reveal any inhibition and zones of inhibition produced by each compound was measured in 
mm. The results of antimicrobial studies are given in Table 1.  
Minimal inhibitory concentration (MIC) measurement  
The bacteriostatic activity of the active compounds (having inhibition zones (IZ) ≥ 16 mm) 
was then evaluated using the two fold serial dilution technique [20]. Two fold serial 
dilutions of the test compounds and reference drugs solutions were prepared using the 
proper nutrient broth. The final concentration of the solutions varied between 500 and 7.81 
μg/ml with the concentration of DMF not exceeding 2.5%. Each 0.10 ml from the tested 
compounds in DMF was mixed with 1 ml, 2 ml, and 3 ml sterilized distilled water and 0.10 
ml from each diluted samples was added to test tubes. The tubes were then inoculated 
with the test organisms, grown in their suitable broth at 37 °C for 24 hours for bacteria and 
48 hours for fungi (about 1×10
6 cells/ml), each 5 ml received 0.10 ml of the above 
inoculum and were incubated at 37 °C for 48 hours. The lowest concentration showing no 
growth was taken as the minimum inhibitory concentration (MIC) (Table 2).  
Conclusions  
The overall results indicated that, the tested compounds showed promising antimicrobial 
activity against bacteria and Fungi. Among the tested compounds, for gram-positive and 
gram-negative bacteria, it was noticed that ß-enaminonitriles of pyrazole ring system 2, 3 
and 4 demonstrated inhibitory activities more than ß-enaminoesters 5 and 6. However, the 
pyridazine derivative 9 and non-acetylated sugar 10 revealed the most significant 
antibacterial activities. On the other hand, the non-acetylated sugar 9 and the acetylated 
cyclic C-nucleoside 10 revealed more effective activity against yeast than the other tested 
compounds. 
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